普拉克索联合美多芭对老年帕金森患者运动功能的影响

2018-01-11 05:30:22陈明祝陈莉莉
中国医药科学 2018年1期
关键词:帕金森病

周 琛 庞 伟 陈明祝 陈莉莉

1.广东省湛江中心人民医院神经内一科,广东湛江 524000;2.广东省湛江市第二人民医院神经内科,广东湛江 524000

普拉克索联合美多芭对老年帕金森患者运动功能的影响

周 琛1庞 伟2陈明祝1陈莉莉1

1.广东省湛江中心人民医院神经内一科,广东湛江 524000;2.广东省湛江市第二人民医院神经内科,广东湛江 524000

目的探讨普拉克索联合美多芭对老年帕金森(PD)患者运动功能的影响。方法选择120例老年PD患者作为研究对象,采用随机数字表法将其均分为美多芭组和联合治疗组各60例,连续治疗9周,观察比较两组患者临床疗效及对运动功能的影响。结果联合治疗组治疗总有效率明显高于美多芭组,差异有统计学意义(P<0.05);治疗后,两组患者UPDRSⅢ评分及H-Y分级情况均得到改善,与治疗前比较,差异有统计学意义(P<0.05);联合治疗组患者UPDRSⅢ评分比美多芭组低,差异有统计学意义(P<0.05),H-Y分级为Ⅰ~Ⅱ级患者明显比美多芭组多,H-Y分级为Ⅲ~Ⅳ级患者明显比美多芭组少,差异有统计学意义(P<0.05);联合治疗组不良反应发生率为15.00%,明显比美多芭组的26.67%低,差异有统计学意义(P<0.05)。结论应用美多芭联合盐酸普拉克索治疗老年PD具有良好的临床效果,对于患者运动功能具有明显的改善作用,且能降低患者不良反应发生情况。

普拉克索;美多芭;老年帕金森;运动功能

R742.5

A

2095-0616(2018)01-81-04

广东省医学科学技术研究基金项目(A2016093);广东省湛江市科技计划项目(20161301003)。

Effects of pramipexole and methadopine on motor function in elderly patients with parkinson's disease

ZHOU Chen1PANG Wei2CHEN Mingzhu1CHEN Lili1
1.Department of Neurology WardⅠ,Zhanjiang People's Central Hospital,Zhanjiang 524000,China;2.Department of Neurology,Zhanjiang Second People's Hospital,Zhanjiang 524000,China

ObjectiveTo investigate the effect of pramipexole and methadopine on motor function in elderly patients with Parkinson’s disease (PD).Methods120 elderly patients with PD were selected as the subjects.The random number table method was used to divide the patients into the metoprol group and the combination therapy group,each group of 60 cases,the patients were treated for 9 weeks, and the clinical efficacy and the impact of motor function of the two groups were observed and compared.ResultsThe total effective rate in the combination therapy group was significantly higher than in the metoprolol group (P<0.05).After treatment,the UPDRSⅢ score and the H-Y grade were improved in the two groups (P<0.05).The UPDRSⅢ score in the combination therapy group was significantly lower than that in the metoprolol group (P<0.05).The H-Y grade Ⅰ-Ⅱ patients were significantly more than themetoprol group,Ⅲ-Ⅳ grade were significantly less than the metoprol group,the difference was statistically significant (P<0.05).The incidence of adverse reactions in the combination therapy group was 15.00%,which was significantly lower than the 26.67% of the metoprolol group,and the difference was statistically significant (P<0.05).ConclusionThe combination of mebopa and piracyol hydrochloride has a good clinical effect in the treatment of elderly patients with PD.It can improve the motor function,and improve the incidence of adverse reactions.

Pramipexole;Methopamine;Elderly Parkinson;Motor function

帕金森病(parkinson's disease,PD)是一种常见于中老年的神经系统变性疾病[1];其病理变化主要为中脑黑质多巴胺能神经元变性死亡,黑质残存神经元胞质内出现路易小体,纹状体多巴胺含量减少,其确切病因至今尚未完全清楚[2-3],目前治疗PD尚无特效药物及根治方案。……

登录APP查看全文

猜你喜欢
帕金森病
关注帕金森病患者的睡眠障碍
中老年保健(2022年5期)2022-08-24 02:34:58
改善生活方式,延缓帕金森病进展
中老年保健(2022年4期)2022-08-22 02:59:22
手抖一定是帕金森病吗
保健医苑(2022年6期)2022-07-08 01:25:28
芝麻素酚或能预防帕金森病
中老年保健(2021年6期)2021-11-30 08:25:27
从虚、瘀、风论治帕金森病
p150Glued在帕金森病模型中的表达及分布
线粒体自噬与帕金森病的研究进展
生物学通报(2021年4期)2021-03-16 05:41:26
帕金森病科普十问
活力(2019年22期)2019-03-16 12:47:04
帕金森病的治疗
中西医结合治疗帕金森病98例